First reports of serious adverse drug reactions in recent weeks

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 1, January 2008 , pp. 22-23(2)

Publisher: Adis International

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

The following table contains an overview of first published case reports of serious adverse drug reactions (ADRs) identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. An event is serious (FDA MedWatch definition) when the patient outcome is death, life-threatening, hospitalisation, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage. Reactions and the customised Reactions Pharmacovigilance Service are produced by Wolters Kluwer Health | Adis and monitor >4000 journals, including relevant MEDLINE-indexed journals, as well as companion journal supplements, major scientific meetings, the newsletters from the >80 national centres participating in the WHO International Drug Monitoring Programme, media releases, pharmaceutical company websites, and regulatory agency websites.

Keywords: Adverse drug reactions

Document Type: Research article

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$32.95 plus tax Refund Policy